ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Sumitomo Chemical will work with the biobased chemical firm Conagen to develop p-hydroxystyrene using a combination of biosynthesis and chemosynthesis. The partners say they will combine Conagen’s expertise in microbial strain design with Sumitomo’s proficiency in chemical production to create a monomer made from 100% renewable carbon. Sumitomo invested $30 million in Conagen in April 2020.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter